Merck (MRK) Dividend Coverage Ratio (QoQ) (2009 - 2026)
Powered by 
Analysis
Merck (MRK) Dividend Coverage Ratio (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.10 Bn | 625.34 Bn | 17.26 Bn |
| 2 | AbbVie | 441.68 Bn | 435.11 Bn | 12.70 Bn |
| 3 | Merck | 366.62 Bn | 359.48 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.55 Bn | 258.86 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - |
| 8 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.06% |
| Mar 31, 2026 | -237.33% |
| Dec 31, 2025 | -48.49% |
| Sep 30, 2025 | 33.65% |
| Jun 30, 2025 | -14.05% |
| Mar 31, 2025 | 29.26% |
| Dec 31, 2024 | 18.56% |
| Sep 30, 2024 | -41.14% |
| Jun 30, 2024 | 12.48% |
| Mar 31, 2024 | 469.28% |
| Dec 31, 2023 | -125.85% |
| Sep 30, 2023 | 180.82% |
| Jun 30, 2023 | -307.81% |
| Mar 31, 2023 | -11.60% |
| Dec 31, 2022 | -7.38% |
| Sep 30, 2022 | -16.54% |
| Jun 30, 2022 | -9.61% |
| Mar 31, 2022 | 7.79% |
| Dec 31, 2021 | -17.40% |
| Sep 30, 2021 | 199.97% |